Pharmafile Logo
Pharmafocus logo
Advanced Search

Bioverativ adds new member to board of directors

March 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …

Appointment
genes

Gene therapy: Advanced treatments for a new era

March 3, 2017
Medical Communications gene therapy

Aranca discusses the considerable advances that have occured in the last few years in gene therapy.Considerable research has been conducted …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …

News
eu_and_fda

EU-US reach landmark deal on mutual recognition of manufacturing inspection

March 3, 2017
Medical Communications EMA, EU, FDA, US

The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …

News

Price cuts bring 14 Cancer Drugs Fund treatments into routine NHS use

March 3, 2017
Medical Communications, Sales and Marketing CDF, NICE

NICE has revealed that it has reached the halfway point in its review of the old Cancer Drugs Fund (CDF) …

News
cma_logo

CMA accuses Concordia and Actavis of illegal agreement to maintain high prices

March 3, 2017
Medical Communications, Sales and Marketing Actavis UK, CMA, Concordia, competition and markets authority

The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …

News

Ipsen appoints new Executive Vice President

March 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen

Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …

Appointment
juno

Juno Therapeutics abandons problem leukaemia drug

March 2, 2017

Juno Therapeutics has finally called time on the development of its CAR-T therapy, JCAR015, after one of the most turbulent …

News
shutterstock_128521253

Are we prepared for the ‘real world’?

March 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing opinion, real world data, recruitment

Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …

Feature

NICE approves first biliary cholangitis drug in 20 years

March 2, 2017
Sales and Marketing Intercept Pharmaceuticals, intercept, liver disease, ocaliva, primary biliary cholangitis

Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …

News
x-ray-1704854_960_720

Osteoporosis drugs potentially causing long-term bone weakness

March 2, 2017
Research and Development osteoporosis

Medication that is used to treat those suffering from weakened bones may actually be causing further damage, new research from …

News
images

Roche’s neoadjuvant breast cancer combo therapy shows strong Phase 3 results

March 2, 2017
Research and Development Herceptin, Perjeta, Roche

Roche’s combination treatment of Perjeta (pertuzumab), Herceptin (trasdtuzumab) and chemotherapy met its primary endpoint in a recent Phase 3 study. …

News
novartis_headquarters

South Korea fines Novartis over kickbacks scandal

March 2, 2017
Medical Communications, Sales and Marketing Kickback, Novartis, south korea

South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …

News
scott_smith_252

New COO for Celgene

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

Appointment

Pfizer plant receives FDA warning letter for contamination of medicine

March 1, 2017
Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics

The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …

News

Graham Dunkley chooses Medica’s Pharma Cartons

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medica Packaging

Medica Packaging is pleased to announce that Graham Dunkley, most recently of Multi Packaging Solutions (MPS) has joined Medica as …

News
Press release
800px-cocainehydrochloridepowder

Promising anti-cocaine treatment aims for human trials within a year

March 1, 2017
Research and Development University of Cincinnati, cocaine, immunotherapy

Researchers at the University of Cincinnati (UC) have developed a monocloncal antibody designed to treat cocaine addiction; its successful showing …

News
lungs

Asthma drugs may have alternative function as pneumonia treatment

March 1, 2017
Research and Development asthma, influenza, pneumonia

Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …

News
kitepharma_fullcolor_rgb_1

Kite Pharma climbs on strong data showing in lymphoma trial

March 1, 2017
Research and Development kite pharma, non-Hodgkin lymphoma

Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …

News
jakob-riis

Novo Nordisk’s Head of North America resigns

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment

Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026